MicroBioGen is an Australian based biotechnology company with global success in improving the industrial capabilities of 𝘚𝘢𝘤𝘤𝘩𝘢𝘳𝘰𝘮𝘺𝘤𝘦𝘴 𝘤𝘦𝘳𝘦𝘷𝘪𝘴𝘪𝘢𝘦. This yeast is the world’s most widely used microorganism, underpinning around US$2 trillion in products, from biofuels and pharmaceuticals to mycoproteins for food and feed. With a proprietary platform technology and library of elite yeast genetics, developed over 20 years, MicroBioGen delivers ‘Yeast Innovation as a Service’ to industry leaders globally. Demonstrated through MicroBioGen’s biofuels partnership with Novonesis and co-developing the Innova® yeast series which delivers unparalleled industrial performance, MicroBioGen is the collaborator of choice for yeast biotechnology, with opportunities in existing and emerging industries, ranging from optimising yeast for baking, sustainable feed and energy to food applications.
Looking for a particular MicroBioGen employee's phone or email?
MicroBioGen Questions
The MicroBioGen annual revenue was $5.3 million in 2026.
Geoffrey Bell is the CEO of MicroBioGen.
23 people are employed at MicroBioGen.
MicroBioGen is based in Sydney, New South Wales.
The NAICS codes for MicroBioGen are [31, 31111, 3111, 311].
The SIC codes for MicroBioGen are [20, 204].
Top MicroBioGen Employees
-
Geoffrey Bell
CEO at MicroBioGen
Sydney, NSW, AU25 -
Jenny Hart
Chief Financial Officer at MicroBioGen
Sydney, NSW, AU11 -
Drew Selwood
Operations Manager at MicroBioGen
Sydney, NSW, AU23 -
Anne Bell
CFO at MicroBioGen
Sydney, NSW, AU -
Heinrich Kroukamp
Deputy Head of Research at MicroBioGen
Macquarie Park, NSW, AU3 -
1
Related Companies
